Global Advisory Firm Continues to Bolster Compliance Expertise with Applied Compliance Data Analytics, Operational Excellence and Healthcare & Pharma/Life Sciences Expert
StoneTurn, a global advisory firm, today announced that Jonathon Kellerman, formerly Executive Vice President, Global Chief Compliance Officer at Allergan, has joined as a Partner based in New York. An expert in helping organizations design innovative, data-driven and business-friendly compliance solutions and programs to proactively manage risk, Jonathon brings a unique mix of practical pharma/life sciences and healthcare-focused in-house compliance and professional services experience to the firm.
At StoneTurn, Jonathon will primarily advise Chief Compliance Officers and Chief Legal Officers, as well as executive leadership and Boards of Directors. He is uniquely positioned to do so, having spent over 26 years assisting diverse healthcare and life science clients on a broad spectrum of compliance and operational issues and serving in-house as a Global Chief Compliance Officer at Allergan.
At Allergan, Jonathon built a risk management and effective compliance program that brought a singular focus on ethics and accountability across a $20B pharmaceutical, medical device, generics, consumer and medical aesthetics company. He was also responsible for all elements of the company’s Corporate Compliance program: anti-bribery/anti-corruption; anti-kickback; anti-money laundering; healthcare compliance; False Claims Act; data privacy; and U.S. and global transparency reporting. He brought data sophistication and innovative analytics to complex risk monitoring and actively supported more than 10 unique product launches. Jonathon managed multiple corporate integrity agreements with the Office of Inspector General and led a range of multi-jurisdictional investigations into bribery and kickback claims, financial fraud claims, pricing schemes and promotional messaging claims, and privacy and security violation claims. Jonathon developed a reputation for progressive and values-based leadership, building a 70-person team that was known for its diversity, innovation and business partnership. Jonathon also led a team responsible for operational and process excellence; he operationalized an industry-leading digital transformation initiative that enabled novel consumer and customer engagement and loyalty while also enhancing compliance and business processes and controls.
A member of the CEO’s Executive Leadership Team at Allergan, Jonathon had broad strategic and operational execution responsibility across the company, including assisting with over $200M in transactions and complex integrations, including pre- and post-deal diligence.
“Corporate compliance leaders are increasingly turning to our professionals for pragmatic insights into how data analytics and other technology-based tools can help them better manage risk,” said Christopher Martinez, Co-Founder and Managing Partner of StoneTurn. “Jonathon brings valuable first-hand insights into building consensus for, and implementing, a novel data analytics and compliance monitoring platform across a heavily-regulated multinational organization. His practical expertise in technology-enhanced compliance will help our clients shift the risk paradigm from managing risk to being more predictive about risk, allowing for a more targeted and risk-based approach to business decision-making.”
Prior to joining Allergan, Jonathon was a Partner at PwC. During his 20-year tenure at PwC, he partnered to launch and build two industry-leading advisory/consulting practices— one focused on the Healthcare Provider sector and the other on the Global Pharmaceutical & Life Sciences sector— that served the industry’s top companies and were ahead of the curve on compliance strategy, design and solutions; operations design and improvement; corporate strategy; and M&A and integration. The practice put him at the forefront of the sector’s significant challenges, including changing commercial and R&D business models with new and escalated operational challenges, advancing digital and social media transformation, increased regulatory scrutiny of digital and healthcare provider engagement, new waves of anti-bribery/anti-corruption enforcement, heightened demands for transparency, and unprecedented pressure on boards and senior executives to increase oversight of compliance.
“I am truly excited and energized to be announced as a new Partner at StoneTurn and to be part of a culture and highly experienced team that strongly encourages collaboration and bringing innovative, leading-edge solutions to our clients’ most complex challenges,” said Kellerman. “I plan to be a different kind of adviser to the Chief Compliance Officer and Chief Legal Officer community, as well as to executive leadership and Boards of Directors. Having actually executed on many of the compliance and operational activities CLOs and CCOs are now responsible for, I bring the credibility of having built a progressive, innovative and impactful compliance program and I look forward to sharing my first-hand insights with clients in the pharmaceutical, life sciences and healthcare industries and beyond.”
Jonathon L. Kellerman
Jonathon Kellerman, a Partner with StoneTurn, brings over 25 years of experience in compliance strategy, program development and execution; controls design; operational excellence; risk assessment and mitigation; complex investigations; and […]